Evidence map›Paper›PMID 29854067›Full record

ArticleThe Pan African medical journal2017

Antifungals susceptibility pattern of

Michel Kengne, Siri Vivian Shu, Julius Mbekem Nwobegahay, Olivia Achonduh

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Pan African medical journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Characterization ofCurrent medical mycology · 2021
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Michel KengneMedical Microbiology and Immunology Department, School of Health Sciences, Catholic University of Central Africa, Yaoundé, Cameroon.
Siri Vivian ShuMedical Microbiology and Immunology Department, School of Health Sciences, Catholic University of Central Africa, Yaoundé, Cameroon.
Julius Mbekem NwobegahayMedical Microbiology and Immunology Department, School of Health Sciences, Catholic University of Central Africa, Yaoundé, Cameroon.
Olivia AchonduhBiotechnology Center, University of Yaoundé I, Cameroon.
Catholic University of Central Africa · CMUniversité de Yaoundé I · CM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionVaginal candidiasis is considered as an important public health problem worldwide and its incidence has increased nowadays. In recent years, inappropriate and disproportionate use of antifungal drugs, automedication as well as non compliance have caused drug resistance.

methodsThis study aimed at determining the

resultsOut of the 245 vaginal smears collected, 94 (38.4%) strains of yeast were isolates among which 43 (45.7%) were

conclusionDespite the noticeable resistance of

Indexed as

AdolescentAdultAntifungal AgentsCameroonCandidaCandidiasis, VulvovaginalCross-Sectional StudiesFemaleHumansMicrobial Sensitivity TestsMiddle AgedProspective StudiesVaginal SmearsYoung AdultAntifungal Agentsantifungals susceptibilityCandida sppVaginal candidiasis

Identifiers

PMID29854067
PMCPMC5966114
OpenAlexW2772377065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.